Success Story: NIW Approval for a Biomedical Science Researcher Specializing in Cancer Biology With Our Assistance
Client’s Testimonial:
"Thank you so much for everything to help me get the I-140 NIW approved!"
On August 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: Taiwan
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: August 5th, 2026
Processing Time: 21 months, 1 day (Premium Processing Upgrade Requested)
Case Summary:
The client’s work sits at the intersection of biomedical science, cancer biology, DNA repair, genome instability, and precision medicine. With a Ph.D. in biology, the client has focused research on investigating the molecular mechanisms of DNA repair and genome stability in cancer. The proposed endeavor was presented as nationally important because it aims to improve therapeutic outcomes for patients with DNA repair–related cancers by identifying key biological mechanisms that influence disease progression and treatment response, as well as potential targets for more effective cancer treatment.
The petition explained that this research addresses an important healthcare need rather than a purely academic question. Cancers linked to genetic mutations remain a significant public health concern, and treatment resistance continues to limit the effectiveness of available therapies. The client’s work using experimental models and modern genomic techniques was presented as part of a broader effort to advance precision medicine, improve treatment strategies, reduce cancer recurrence, and support better patient outcomes.
At the time of filing, the client was conducting research at a U.S. cancer research center, where the client continued working on cancer-related DNA repair studies and exploring how genetic alterations influence tumor development and treatment response. These ongoing plans helped demonstrate a clear connection between the client’s prior record and future contributions in the United States.
To show that the client was well positioned to advance this endeavor, the petition relied on a focused record of scholarly output and peer recognition. The client’s record included 4 peer-reviewed journal articles, including 2 first-authored articles, 1 first-authored conference abstract, 1 co-first-authored preprint, 38 citations, and 1 completed peer review. Rather than presenting these figures as automatically persuasive, the petition explained how they demonstrated a developing but highly relevant research portfolio in biomedical science, cancer biology, DNA repair, developmental biology, and molecular mechanisms of disease.
The petition further demonstrated the client’s significance by showing how other researchers had relied on the client’s work in several areas of biomedical and cancer-related research. North America Immigration Law Group connected these examples to show that the client’s findings had practical value beyond publication, especially for researchers studying DNA repair, cancer mechanisms, reproductive biology, and molecular development.
The petition also placed the client’s citation record in context. We highlighted that 1 of the client’s papers ranked among the top 10% most-cited Clinical Medicine articles for its publication year. This evidence helped show that the client’s work had received meaningful attention from the research community and had been relied upon by others in a field closely connected to the proposed endeavor.
The case was also supported by 2 letters of recommendation from experts in the field. These letters helped explain the client’s technical role in advancing biomedical science and cancer-related DNA repair research, while also connecting the client’s research record to the broader need for more effective and targeted therapeutic strategies. One expert noted:
"Ensuring the continuation of [Client's] work is thus deeply important to both biomedical science research and to the nation."
With a premium processing upgrade requested, the client’s I-140 NIW petition was approved without an RFE. This approval reflects the successful presentation of a case grounded in biomedical science expertise, cancer-focused DNA repair research, independent scholarly reliance, peer recognition, and the national importance of advancing precision medicine and therapeutic strategies for cancers in the United States.